Clinical commissioning policy: Lenacapavir for multi-drug resistant human immunodeficiency virus 1 infection (adults)

Document first published:
Page updated:
Topic:
Publication type:

Lenacapavir for mult-drug resistant human immunodeficiency virus 1 will be routinely commissioned and made by NHS England following a recommendation from the Clinical Priorities Advisory Group.

Document

Clinical commissioning policy: Lenacapavir for multi-drug resistant human immunodeficiency virus 1 infection (adults)

Clinical commissioning policy: Lenacapavir for multi-drug resistant human immunodeficiency virus 1 infection (adults)

  • PDF
  • 229 KB
  • 10 pages

Summary

Published 16 July 2026.